-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Dogwood Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2020 to Q3 2024.
- Dogwood Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$2.28M, a 84.7% decline year-over-year.
- Dogwood Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$5.73M, a 8.22% increase year-over-year.
- Dogwood Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$5.3M, a 56.8% increase from 2022.
- Dogwood Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$12.2M, a 23.3% increase from 2021.
- Dogwood Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$16M, a 54.3% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)